节点文献
以端粒末端DNAs为靶分子的抗癌药物的研究进展
Research Progress of the Anticancer Drug Taking an Endmost DNAs as Target Molecule
【摘要】 端粒末端G-四股螺旋DNAs可以抑制端粒酶的键合,进一步抑制癌细胞的生长和大量繁殖。因此,端粒DNAs已成为具有抗癌药物作用的靶分子,能键合并稳定G-四股螺旋DNAs的小分子化合物是潜在的抗肿瘤药物。设计和合成能特异性靶向G-四股螺旋DNAs并显著抑制端粒酶活性的配体成为当今抗癌药物研究的又一大热点。叙述了近年来以端粒G-四股螺旋DNAs为靶分子的抗癌药物设计、合成的最新进展。
【Abstract】 An endmost G four shares of spiral DNAs can suppress the key of an enzyme and growth and breed of the cancer cell further in a large amount.So endmost grains DNAs has already become target molecule with anticancer function,which can key amalgamate stability G four shares of spiral DNAs.Research progress of design and synthesis of the anticancer drug taking an endmost G four shares of spira DNAs as target molecule in recent years has been explained.
【关键词】 端粒DNA;
端粒酶;
抗癌药物;
合成;
【Key words】 endmost grains DNA; endmost enzyme; anticancer drug; synthesis;
【Key words】 endmost grains DNA; endmost enzyme; anticancer drug; synthesis;
【基金】 国家自然科学基金项目资助(20503029,20673110)
- 【文献出处】 太原科技 ,Taiyuan Science & Technology , 编辑部邮箱 ,2007年07期
- 【分类号】R979.1
- 【被引频次】1
- 【下载频次】301